Endocrinology (all articles)
Randomized Controled Trial: Continuous glucose monitoring in pregnant women with type 1 diabetes
25 Sep, 2017 | 22:23h | UTCContinuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial – The Lancet (link to abstract – $ for full-text)
Commentaries: In Pregnant Women with Type 1 Diabetes, Continuous Glucose Monitoring Linked to Better Outcomes – Physician’s First Watch (free) AND All pregnant women with type 1 diabetes should be offered continuous glucose monitoring – OnMedica (free)
Randomized Controled Trial: Post–Cesarean Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women
24 Sep, 2017 | 21:33h | UTCEffect of Post–Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentaries: Post-Cesarean Antibiotics Reduce Risk for Surgical Site Infections in Obese Women – Physician’s First Watch (free) AND Antibiotics After C-Section Cut Infections in Obese Women – MedPage Today (free registration required) AND Antibiotics cut infection risk in obese women after caesarean – OnMedica (free)
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
24 Sep, 2017 | 21:21h | UTCWeight and Metabolic Outcomes 12 Years after Gastric Bypass – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Benefits of gastric bypass persist for 12 years – Reuters (free) AND Gastric bypass surgery benefits continue for 12 years – Diabetes.co.uk (free) AND Bariatric Surgery’s Benefits Last Over a Decade – Physician’s First Watch (free)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
24 Sep, 2017 | 20:18h | UTCEditorial: Romosozumab — Promising or Practice Changing? (free)
Artificial sweeteners raise risk of type 2 diabetes, study suggests
24 Sep, 2017 | 20:07h | UTCArtificial sweeteners raise risk of type 2 diabetes, study suggests – The Guardian (free)
52-week programme leads to more weight loss than 12-week
24 Sep, 2017 | 00:25h | UTC52-week programme leads to more weight loss than 12-week – NIHR Signal (free)
Original article: Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial – The Lancet (free) AND Commentary: Weight management programmes of extended duration (free)
“Although short-term costs higher, referring people to a 52-week programme is probably more cost-effective long-term” (RT @NIHR_DC see Tweet)
Review: Eating Disorders and Disordered Eating Symptoms in Adolescents with Type 1 Diabetes
24 Sep, 2017 | 00:19h | UTCEating Disorders and Disordered Eating Symptoms in Adolescents with Type 1 Diabetes – Nutrients (free)
Cohort Study: Metabolically Healthy Obese and Incident Cardiovascular Disease Events
20 Sep, 2017 | 22:23h | UTCMetabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women – Journal of The American College of Cardiology (link to abstract – $ for full-text)
Commentaries: New evidence shows that healthy obesity is a myth – The Conversation (free) AND Study shows so-called ‘healthy obesity’ is harmful to cardiovascular heath – Medical News Today (free) AND Obesity, even without other risk factors, leads to higher rate of cardiovascular disease – STAT (free) AND Another Study Challenges Notion of ‘Healthy Obese’ – TCTMD (free)
See related article and commentaries in our August 21st issue (see #1)
Retrospective Cohort: Characteristics of Diabetes of the Exocrine Pancreas
20 Sep, 2017 | 20:45h | UTCIncidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study – Diabetes Care (link to abstract – $ for full-text)
Commentary: Glycemic control poor, insulin use high in diabetes after pancreatic disease – Haelio (free registration required)
“Diabetes following pancreatic disease associated with poor glycemic control compared with T2 diabetes” (RT @kamleshkhunti see Tweet)
Guideline: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons
20 Sep, 2017 | 20:35h | UTCJAMA Clinical Guidelines Synopsis: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons (free)
Guideline: Type 2 diabetes – prevention in people at high risk
18 Sep, 2017 | 14:14h | UTC
Cohort Study: Meat, Dietary Heme Iron, and Risk of Type 2 Diabetes Mellitus
18 Sep, 2017 | 14:09h | UTCMeat, Dietary Heme Iron, and Risk of Type 2 Diabetes Mellitus: The Singapore Chinese Health Study – American Journal of Epidemiology (link to abstract – $ for full-text)
Commentary: Eating meat linked to higher risk of diabetes – DukeNUS Medical School, via EurekAlert (free)
Related articles: Meat Consumption as a Risk Factor for Type 2 Diabetes – Nutrients (free) AND Meat consumption and the risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies – Diabetologia (free) AND Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis – American Journal of Clinical Nutrition (free)
“The Singapore Chinese Health Study reveals increased risk of diabetes with higher intake of red meat and poultry, partially attributed to the dietary iron content in these meats” (from EurekAlert)
Study: pioglitazone versus sulfonylureas in patients with type 2 diabetes
18 Sep, 2017 | 14:04h | UTCEffects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: Sulfonylureas, Pioglitazone Similarly Safe for Add-On Therapy in Type 2 Diabetes – Physician’s First Watch (free)
Study: Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance
18 Sep, 2017 | 13:56h | UTCEffects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: Acarbose Offers No CVD Protection in ACE, but May Cut Diabetes Risk – Medscape (free registration required)
Study: Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
16 Sep, 2017 | 18:23h | UTCMenopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials – JAMA (link to abstract – $ for full-text)
Commentaries: Taking Hormones for Menopause Doesn’t Raise Early Death Risk – The New York Times (free) AND Menopause hormone therapy not linked to premature death – Reuters (free) AND Menopause hormones don’t shorten lives, long follow-up says – STAT (free)
Study: LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men
16 Sep, 2017 | 18:20h | UTCCommentary: Statins cut heart deaths in men by 28% finds study – NHS Choices (free)
Review: Current Advances in Thyroid Cancer Management
16 Sep, 2017 | 18:16h | UTC
Metformin: a review of its potential indications
16 Sep, 2017 | 18:05h | UTCMetformin: a review of its potential indications – Drug Design, Development and Therapy (free)
Review: Osteoporosis drug treatment: duration and management after discontinuation
15 Sep, 2017 | 19:09h | UTC
Guideline: Treatment of Type 1 Diabetes
12 Sep, 2017 | 21:11h | UTC
Review: Present and future perspectives for medical therapy of nonfunctioning pituitary adenoma
12 Sep, 2017 | 20:55h | UTC
Review: Polycystic ovary syndrome and nonalcoholic fatty liver disease
12 Sep, 2017 | 20:55h | UTCPolycystic ovary syndrome and nonalcoholic fatty liver disease – European Journal of Endocrinology (free)
Free Online Course: Easing the burden of obesity, diabetes and cardiovascular disease
11 Sep, 2017 | 01:07h | UTCStarts Today! Free Online Course: Easing the burden of obesity, diabetes and cardiovascular disease – University of Sidney and Coursera
Report: Size matters: The impact of upselling on weight gain
10 Sep, 2017 | 01:34h | UTCSee also: Press release (free)
Commentaries: Supersize us: upselling is fuelling the obesity epidemic, warns report – The Guardian (free) AND Going Large – Is Upselling Making You Gain Weight? – Medscape (free registration required)
Cohort Studies: Extreme high HDL cholesterol is paradoxically associated with high mortality
10 Sep, 2017 | 01:33h | UTCCommentaries: High levels of ‘good’ cholesterol linked to excessive mortality – University of Copenhagen, via ScienceDaily (free) AND Does ‘good cholesterol’ really deserve its name? – The Conversation (free) AND Can Your “Good” Cholesteral Be To High? – The New York Times (10 articles per month are free)